JANE M STAUNTON, R.N.
Nursing at Albany St, Boston, MA
License number
Massachusetts 118218
Category
Nursing
Type
Registered Nurse
Address
Address
780 Albany St, Boston, MA 02118
Phone
(857) 654-1000
(857) 654-1094 (Fax)
(857) 654-1094 (Fax)
Personal information
See more information about JANE M STAUNTON at radaris.comName
Address
Phone
12 Knoll St, Roslindale, MA 02131
201 Plymouth Ave, Quincy, MA 02169
9 Hawthorne St, Cambridge, MA 02138
49 Prince St, Jamaica Plain, MA 02130
14 Castleton St #2, Jamaica Plain, MA 02130
Professional information
Jane M Staunton, Boston MA - RN (Registered Nurse)
Specialties:
Nursing (Registered Nurse)
Address:
780 Albany St, Boston 02118
(857) 654-1000 (Phone), (857) 654-1094 (Fax)
(857) 654-1000 (Phone), (857) 654-1094 (Fax)
Languages:
English
Methods And Reagents For The Treatment Of Immunoinflammatory Disorders
US Patent:
2005027, Dec 8, 2005
Filed:
May 16, 2005
Appl. No.:
11/130426
Inventors:
Palaniyandi Manivasakam - West Roxbury MA, US
Jane Staunton - Roslindale MA, US
Curtis Keith - Boston MA, US
Jane Staunton - Roslindale MA, US
Curtis Keith - Boston MA, US
Assignee:
CombinatoRx, Incorporated - Boston MA
International Classification:
A61K039/395, A61K038/13, A61K031/4745, A61K031/192, A61K031/522, A61K031/59, A61K031/415
US Classification:
424144100, 514011000, 514291000, 514406000, 514569000, 514570000, 514167000, 514166000, 514454000, 514567000, 514649000, 514263310
Abstract:
The invention involves the treatment, prevention, and reduction of immunoinflammatory disorders involving the combination of an agent that increases the signal activity of a glucocorticoid receptor (e.g., glucocorticoid receptor agonist) and an agent that modulates the signaling activity of one or more signaling pathways selected from the NF-κB pathway, NFAT pathway, AP-1 pathway, and Elk-1 pathway such that proinflammatory cytokine secretion or production, or any other inflammatory response, is reduced. Further, screening methods are provided for identifying candidate compounds and strategies useful for treating, preventing, or reducing such conditions.
Methods And Compositions For Treatment Of Muscular Dystrophy
US Patent:
2011022, Sep 15, 2011
Filed:
Apr 13, 2010
Appl. No.:
12/759268
Inventors:
Anne Whalen - Medway MA, US
Jane Staunton - Roslindale MA, US
Janine Steiger - South Boston MA, US
Amy B. Wilson - Marlborough MA, US
Yang Wu - Reading MA, US
Jane Staunton - Roslindale MA, US
Janine Steiger - South Boston MA, US
Amy B. Wilson - Marlborough MA, US
Yang Wu - Reading MA, US
International Classification:
A61K 38/02, A61K 31/573, A61K 31/58, A61K 31/519, A61K 31/5513, A61K 31/445, A61K 31/407, A61K 31/436, A61K 31/437, A61K 31/47, A61K 31/52, A61K 31/4985, A61K 31/50, A61K 31/122, A61K 31/663, A61K 31/713, A61P 21/00
US Classification:
514 11, 514171, 5142621, 514218, 514315, 514411, 514291, 514293, 514311, 5142634, 514307, 514249, 514247, 514678, 514108, 514 44 A
Abstract:
The invention features methods, compositions, and kits useful for the treatment of muscular dystrophy, e.g., Duchenne muscular dystrophy, in a patient.
Compositions And Methods For The Treatment Of Neurodegenerative Diseases
US Patent:
2006028, Dec 21, 2006
Filed:
May 2, 2006
Appl. No.:
11/415926
Inventors:
Jane Staunton - Roslindale MA, US
Xiaowei Jin - Cambridge MA, US
Dina Rufo - South Weymouth MA, US
Michael Monteiro - Malden MA, US
Xiaowei Jin - Cambridge MA, US
Dina Rufo - South Weymouth MA, US
Michael Monteiro - Malden MA, US
International Classification:
A61K 31/551, A61K 31/375, A61K 9/20, A61K 31/195
US Classification:
424464000, 514218000, 514561000, 514474000
Abstract:
The invention features compositions and methods for the treatment of neurodegenerative diseases.
Compositions And Methods For The Treatment Of Neurodegenerative Diseases
US Patent:
2006027, Nov 30, 2006
Filed:
May 2, 2006
Appl. No.:
11/415786
Inventors:
Jane Staunton - Roslindale MA, US
Xiaowei Jin - Cambridge MA, US
Dina Rufo - South Weymouth MA, US
Michael Monteiro - Malden MA, US
Xiaowei Jin - Cambridge MA, US
Dina Rufo - South Weymouth MA, US
Michael Monteiro - Malden MA, US
International Classification:
A61K 31/13
US Classification:
514663000, 514474000, 514571000
Abstract:
The invention features compositions and methods for the treatment of neurodegenerative diseases.
Jane Staunton
Location:
Greater Boston Area
Industry:
Pharmaceuticals